AAAAAA
Results:
1-8
|
Results: 8
Authors:
Eckard, CP
Cabrele, C
Wieland, HA
Beck-Sickinger, AG
Citation: Cp. Eckard et al., Characterisation of neuropeptide Y receptor subtypes by synthetic NPY analogues and by anti-receptor antibodies, MOLECULES, 6(5), 2001, pp. 448-467
Authors:
Wieland, HA
Hamilton, BS
Citation: Ha. Wieland et Bs. Hamilton, Weighing the options in the pharmacotherapy of obesity, INT J CL PH, 39(9), 2001, pp. 406-414
Authors:
Cabrele, C
Wieland, HA
Langer, M
Stidsen, CE
Beck-Sickinger, AG
Citation: C. Cabrele et al., Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y-5-receptor ligands with picomolar affinity, PEPTIDES, 22(3), 2001, pp. 365-378
Authors:
Wieland, HA
Hamilton, BS
Krist, B
Doods, HN
Citation: Ha. Wieland et al., The role of NPY in metabolic homeostasis: implications for obesity therapy, EXPERT OP I, 9(6), 2000, pp. 1327-1346
Authors:
Cabrele, C
Langer, M
Bader, R
Wieland, HA
Doods, HN
Zerbe, O
Beck-Sickinger, AG
Citation: C. Cabrele et al., The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats, J BIOL CHEM, 275(46), 2000, pp. 36043-36048
Authors:
Weiser, T
Wieland, HA
Doods, HN
Citation: T. Weiser et al., Effects of the neuropeptide YY2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices, EUR J PHARM, 404(1-2), 2000, pp. 133-136
Authors:
Eckard, CP
Beck-Sickinger, AG
Wieland, HA
Citation: Cp. Eckard et al., Comparison of antibodies directed against receptor segments of NPY-receptors, J RECEPT SI, 19(1-4), 1999, pp. 379-394
Authors:
Doods, H
Gaida, W
Wieland, HA
Dollinger, H
Schnorrenberg, G
Esser, F
Engel, W
Eberlein, W
Rudolf, K
Citation: H. Doods et al., BIIE0246: A selective and high affinity neuropeptide YY2 receptor antagonist, EUR J PHARM, 384(2-3), 1999, pp. R3-R5
Risultati:
1-8
|